版本:
中国

BRIEF-U.S. district court invalidates four Acorda Therapeutics Ampyra patents

March 31 Acorda Therapeutics Inc:

* U.S. district court issues decision to invalidate four Ampyra patents; company will appeal ruling

* Company has developed contingency plans to address its business needs and objectives in event of a loss of Ampyra exclusivity Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐